CNTA Insider Trading Activity and SEC Form 4 Filings

CNTA insider trading summary

Over the past 12 months, insiders at Centessa Pharmaceuticals plc (CNTA) reported 78 sales worth $9.2M by 17 insiders and no open-market purchases on SEC Form 4. Net insider selling was $9.2M.

Latest CNTA insider buys and sells

DateInsiderTypeValue
Jun 24, 2026Medicxi Ventures I LPSell$0
Jun 24, 2026Medicxi Co-Invest I LPSell$0
Jun 24, 2026Medicxi Ventures Management (Jersey) LtdSell$0
Jun 24, 2026Index Venture Life Associates VI LtdSell$0
Jun 24, 2026(Jersey) SLP YuccaSell$0
Jun 24, 2026Index Ventures Life Vi (jersey) L.P.Sell$0
Jun 24, 2026Index Ventures Life Vi (jersey) L.P.Sell$0
Jun 24, 2026(Jersey) SLP YuccaSell$0
Jun 24, 2026Index Venture Life Associates VI LtdSell$0
Jun 24, 2026Medicxi Ventures I GP LtdSell$0

Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.

CNTA Insider Trading: Insider Buys & Sells | Insidra